Rapid and early diagnosis of tuberculosis in household contacts of cases with the disease in Havana, Cuba (COMBO.X-TB)
Diaz-Rodriguez, R.; Martinez-Rodriguez, A.; Martinez-Romero, M. R.; Abreu-Suarez, G.; Gonzalez-Diaz, A.; Mitchell, E. M. H.
Show abstract
Since 2014, Cubas National Tuberculosis Control and Elimination Program (PNCET, acronym in Spanish) has been using the Xpert(R) MTB/RIF technique (Cepheid, Sunnyvale, CA, USA) for rapid molecular diagnosis of tuberculosis (TB). Due to financial limitations and difficult access to kits and cartridges (both of which are of U.S. origin), this test is only intended for prioritized vulnerable groups. Thus, only one third of the cases reported annually are diagnosed by rapid tests, as an initial technique. The scope of Xpert diagnosis can be increased by using the pooling sputum method, where several sputum samples from different persons are pooled and applied in a single Xpert(R) MTB/RIF Ultra (or simply Xpert Ultra) cartridge. This method of pooling sputum with the Xpert Ultra has been used with samples from symptomatic respiratory patients from countries with a high burden of disease, and its use could be extended to household contacts without expectoration, over 8 years of age. Sputum may not always be produced spontaneously in people with incipient, asymptomatic disease, and children often have problems expectorating. The use of a positive expiratory pressure (PEP) device, Lung Flute (LF) ECO (Acoustic Innovation, Tokyo, Japan), helps to produce sputum more easily and its result could be very similar to the use of a hypertonic solution. To increase rapid molecular diagnosis in people with suspected TB and at an early stage of the disease, this project aims to: 1. evaluate the pooled sputum method and the Xpert Ultra molecular assay in the rapid diagnosis of TB in household contacts of cases with bacteriologically confirmed pulmonary TB. 2. Estimate the proportion of household contacts that are able to produce a sputum sample suitable for Xpert Ultra using the LF ECO device. In Latin America, Xpert(R) MTB/RIF, and more recently Xpert Ultra, is used in almost all countries as the first TB diagnostic technique, but the percentages are still low, mainly due to the scarce economic resources available in the region. Therefore, the use of novel strategies, such as the use of sample mixtures pooled in a single Xpert Ultra cartridge, will increase the coverage of testing for TB cases, reduce the sources of infection in the community and reduce the costs of cases diagnosed by rapid tests. This study will provide important information on the combination of a powerful molecular tool (Xpert(R) MTB/RIF Ultra) for TB diagnosis, the application of a pooling sputum method and the use of a PEP device, Lung Flute ECO, in household contacts with and without respiratory symptoms. The synergistic methods in this study could serve as a reference for other countries in the process of TB elimination. These countries need to vastly increase their testing to find a rapidly shrinking number of cases, and our efficient strategy represents a potentially sustainable way to do this. Low income countries face challenging hurdles to acquire sufficient imported proprietary consumables for high volume testing. Pooling is increasingly viewed as a way to promote equity and access in settings without preferential pricing or favorable trade relations.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Comparison of tests done, and Tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda 97%
- High Proportion of RR-TB and mutations conferring RR outside of the RRDR of the rpoB gene detected in GeneXpert MTB/RIF assay positive pulmonary tuberculosis cases, in Addis Ababa, Ethiopia 97%
- The Pattern of rpoB gene mutation of Mycobacterium tuberculosis and predictors of rifampicin resistance detected by gene Xpert MTB/Rif in Tanzania 96%
Similar papers in this journal
- Evaluating the PATHFAST TB LAM Ag Assay as a Treatment Monitoring Tool for Pulmonary Tuberculosis : Protocol for a Prospective Longitudinal Study in Nairobi, Kenya 96%
- Exploring the Role of Microbiome in Susceptibility, Treatment Response and Outcome among Tuberculosis Patients from Pakistan; Study Protocol for a Prospective Cohort Study (Micro-STOP) 96%
- Epidemiology of Extrapulmonary Tuberculosis in Brunei Darussalam 95%
Similar papers in this journal
Similar papers in this journal
- Healthcare seeking behavior and delays in case of drug-resistant Tuberculosis patients in Bangladesh: Findings from a cross-sectional survey 95%
- Treatment preferences among people at risk of developing tuberculosis: a discrete choice experiment 95%
- Evaluating the health impact, health-system costs and cost-effectiveness of using TrueNat on stool samples compared to usual care for the diagnosis of paediatric tuberculosis in primary care settings: a modelling analysis 95%
Similar papers in this journal
- Stool processing methods for Xpert Ultra testing in childhood tuberculosis: A prospective, multi-country accuracy study 95%
- Diagnostic performance of the Pluslife MiniDock MTB and Molbio MTB Ultima assays to detect tuberculosis from tongue and sputum swabs among outpatients and in active case finding in Cameroon 95%
- Sputum and tongue swab molecular testing for the in-home diagnosis of tuberculosis in unselected household contacts: a cost and cost-effectiveness analysis 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.